Article metrics

Download PDFPDF

Extended report
Clinical benefit of 1-year certolizumab pegol (CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritis was observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial

 

Online download statistics by month:

Online download statistics by month: February 2017 to September 2021

AbstractFullPdf
Feb 2017802434661
Mar 201711357260
Apr 20170303110
May 20171347178
Jun 2017106540186
Jul 2017542542190
Aug 2017317313147
Sep 2017222222124
Oct 2017207207121
Nov 2017224222106
Dec 201727326762
Jan 201820019837
Feb 201817416441
Mar 201828927545
Apr 201819119731
May 201813313830
Jun 201810510340
Jul 201812512345
Aug 201817017132
Sep 201811911927
Oct 201816516529
Nov 201824824831
Dec 201817217233
Jan 201913413416
Feb 201912012025
Mar 2019797828
Apr 2019777639
May 2019606023
Jun 2019474633
Jul 2019605932
Aug 2019494816
Sep 2019616117
Oct 2019636027
Nov 2019565440
Dec 2019474026
Jan 2020505022
Feb 2020544533
Mar 2020524125
Apr 2020464034
May 2020525162
Jun 2020322626
Jul 2020454127
Aug 2020434030
Sep 2020826437
Oct 2020949227
Nov 2020735839
Dec 2020654120
Jan 2021494329
Feb 2021353517
Mar 2021454127
Apr 2021151314
May 2021343310
Jun 2021454524
Jul 2021242418
Aug 2021403928
Sep 2021373521
Total666175603458